Impact of the dead-time correction method on quantitative ¹⁷⁷Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy.

"Declarations Ethics approval and consent to participatePatient images and data used in this analysis were from participants in our P-PRRT trial (NCT02754297), which is approved by our institutional ethics committee. Patients gave informed consent to participate. Consent for publicationAll authors read the manuscript and consented for its publication. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding AD is the recipient of a Bourse interfacultaire from Cancer Research Centre, Université Laval. JMB is supported by a Clinical Research Scholarship from the Fonds de recherche du Québec—Santé. This work was funded by the Canadian Institutes of Health Research (CIHR) operating grant MOP-142233 to JMB. No other potential conflict of interest relevant to this article was reported."